RI
MRNA icon

Redwood Investments’s Moderna MRNA Stock Holding History

Redwood Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,700
Closed -$571K – 118
2023
Q2 		$571K Sell
4,700
-15,927
-77% -$2.12M 0.07% 99
2023
Q1 		$3.17M Buy
20,627
+599
+3% +$98.8K 0.4% 71
2022
Q4 		$3.6M Buy
20,028
+11,538
+136% +$1.89M 0.48% 65
2022
Q3 		$1M Sell
8,490
-808
-9% -$123K 0.13% 86
2022
Q2 		$1.33M Buy
9,298
+2,840
+44% +$406K 0.15% 90
2022
Q1 		$1.11M Sell
6,458
-9,446
-59% -$1.59M 0.11% 98
2021
Q4 		$4.04M Buy
15,904
+666
+4% +$195K 0.32% 77
2021
Q3 		$5.86M Sell
15,238
-1,100
-7% -$406K 0.49% 65
2021
Q2 		$3.84M Buy
16,338
+11,338
+227% +$2.03M 0.31% 79
2021
Q1 		$655K Buy
+5,000
New +$725K 0.06% 104

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Redwood Investments's MRNA Position: Q3 2023 in Review

Redwood Investments sold out of Moderna (MRNA) in Q3 2023, closing a stake of 4,700 shares — an estimated $571K sold.

Redwood Investments first reported a position in MRNA in Q1 2021 and held it in 10 quarters. The position peaked at $5.86M in Q3 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Redwood Investments reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Redwood Investments sold 4,700 Moderna shares in Q3 2023, an estimated $571K.
  • Redwood Investments first reported a position in Moderna in Q1 2021 and held it in 10 quarters.
  • Redwood Investments's Moderna position peaked at $5.86M in Q3 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Redwood Investments's 13F filing for Q3 2023, filed 24 Oct 2023.